L. Softic

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity

J. Pawlotsky, N. Jouvenet, P. Bruscella, 2018, Antimicrobial Agents and Chemotherapy.

Proviral role of human respiratory epithelial cell‐derived small extracellular vesicles in SARS‐CoV‐2 infection

J. Pawlotsky, V. Firlej, P. Maillé, 2022, Journal of extracellular vesicles.

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry

J. Pawlotsky, S. Jamain, P. Maillé, 2022, Scientific Reports.

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)

J. Pawlotsky, P. Bruscella, S. Fourati, 2020, Antimicrobial Agents and Chemotherapy.

MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication

J. Pawlotsky, E. Hernández, S. Fourati, 2020, Antimicrobial Agents and Chemotherapy.

Oral ivermectin for a scabies outbreak in a long‐term care facility: potential value in preventing COVID‐19 and associated mortality

B. Giraudeau, O. Chosidow, C. Chenost, 2021, The British journal of dermatology.